US pharmaceutical invests €1bn in Swords
MSD Ireland has opened a new manfacturing facility in Swords to develop its new cancer drug. This is a major investment in the Swords site at Drynam, just north of Holywell, and will see the workforce at the site increase from 350 to 420. The new facility will develop the cancer drug Keytruda which helps…